Literature DB >> 33947048

Hemistepsin a Induces Apoptosis of Hepatocellular Carcinoma Cells by Downregulating STAT3.

Il Je Cho1, Jae Kwang Kim1,2, Eun Ok Kim1, Sang Mi Park1, Sang Chan Kim1, Sung Hwan Ki3, Sae Kwang Ku1.   

Abstract

Hemistepta lyrata (Bunge) Bunge is a biennial medicinal plant possessing beneficial effects including anti-inflammation, and hemistepsin A (HsA) isolated from H. lyrata has been known as a hepatoprotective sesquiterpene lactone. In this report, we explored the cytotoxic effects of H. lyrata on hepatocellular carcinoma (HCC) cells and investigated the associated bioactive compounds and their relevant mechanisms. From the viability results of HCC cells treated with various H. lyrata extracts, HsA was identified as the major compound contributing to the H. lyrata-mediated cytotoxicity. HsA increased expression of cleaved PARP and cells with Sub-G1 phase, Annexin V binding, and TUNEL staining, which imply HsA induces apoptosis. In addition, HsA provoked oxidative stress by decreasing the reduced glutathione/oxidized glutathione ratio and accumulating reactive oxygen species and glutathione-protein adducts. Moreover, HsA inhibited the transactivation of signal transducer and activator of transcription 3 (STAT3) by its dephosphorylation at Y705 and glutathione conjugation. Stable expression of a constitutive active mutant of STAT3 prevented the reduction of cell viability by HsA. Finally, HsA enhanced the sensitivity of sorafenib-mediated cytotoxicity by exaggerating oxidative stress and Y705 dephosphorylation of STAT3. Therefore, HsA will be a promising candidate to induce apoptosis of HCC cells via downregulating STAT3 and sensitizing conventional chemotherapeutic agents.

Entities:  

Keywords:  Hemistepta lyrata (Bunge) Bunge; apoptosis; hemistepsin A (HsA); hepatocellular carcinoma (HCC) cells; oxidative stress; signal transducer and activator of transcription 3 (STAT3); sorafenib

Year:  2021        PMID: 33947048     DOI: 10.3390/ijms22094743

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  43 in total

Review 1.  New knowledge of the mechanisms of sorafenib resistance in liver cancer.

Authors:  Yan-Jing Zhu; Bo Zheng; Hong-Yang Wang; Lei Chen
Journal:  Acta Pharmacol Sin       Date:  2017-03-27       Impact factor: 6.150

Review 2.  Activation of apoptosis signalling pathways by reactive oxygen species.

Authors:  Maureen Redza-Dutordoir; Diana A Averill-Bates
Journal:  Biochim Biophys Acta       Date:  2016-09-17

3.  Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

Authors:  Diego F Calvisi; Sara Ladu; Alexis Gorden; Miriam Farina; Elizabeth A Conner; Ju-Seog Lee; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

4.  The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation.

Authors:  Tetsuya Yamamoto; Yuichi Sekine; Keiichi Kashima; Atsuko Kubota; Noriko Sato; Naohito Aoki; Tadashi Matsuda
Journal:  Biochem Biophys Res Commun       Date:  2002-10-04       Impact factor: 3.575

5.  Vacquinol‑1 induces apoptosis in hepatocellular carcinoma cell.

Authors:  Shu-Lan Sun; Xiaoxi Li; Nan Su; Shi Chen; Xiaoxin Gao; Guirong Zhang; Haozhe Piao
Journal:  Mol Med Rep       Date:  2018-05-03       Impact factor: 2.952

Review 6.  STAT3 signaling mediates tumour resistance to EGFR targeted therapeutics.

Authors:  Ahmad A Zulkifli; Fiona H Tan; Tracy L Putoczki; Stanley S Stylli; Rodney B Luwor
Journal:  Mol Cell Endocrinol       Date:  2017-01-12       Impact factor: 4.102

7.  Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation.

Authors:  J-T Cheng; Y-N Deng; H-M Yi; G-Y Wang; B-S Fu; W-J Chen; W Liu; Y Tai; Y-W Peng; Q Zhang
Journal:  Oncogenesis       Date:  2016-02-22       Impact factor: 7.485

8.  The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma.

Authors:  Liangtao Ye; Julia Mayerle; Andreas Ziesch; Florian P Reiter; Alexander L Gerbes; Enrico N De Toni
Journal:  Cell Death Discov       Date:  2019-04-05

9.  Hemistepsin A suppresses colorectal cancer growth through inhibiting pyruvate dehydrogenase kinase activity.

Authors:  Ling Jin; Eun-Yeong Kim; Tae-Wook Chung; Chang Woo Han; So Young Park; Jung Ho Han; Sung-Jin Bae; Jong Rok Lee; Young Woo Kim; Se Bok Jang; Ki-Tae Ha
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

10.  Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma.

Authors:  Su Youn Baek; Ui Wook Hwang; Ho Young Suk; Young Woo Kim
Journal:  Biomolecules       Date:  2020-05-04
View more
  2 in total

1.  PIAS3/SOCS1-STAT3 axis responses to oxidative stress in hepatocellular cancer cells.

Authors:  Honghua Sun; Yanglong Li; Xianglan Quan; Ning Chen; Xinglin Jin; Wenbiao Jin; Yongmin Jin; Xionghu Shen
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

2.  Inhibition of Autophagy Promotes Hemistepsin A-Induced Apoptosis via Reactive Oxygen Species-Mediated AMPK-Dependent Signaling in Human Prostate Cancer Cells.

Authors:  Kwang-Youn Kim; Un-Jung Yun; Seung-Hee Yeom; Sang-Chan Kim; Hu-Jang Lee; Soon-Cheol Ahn; Kwang-Il Park; Young-Woo Kim
Journal:  Biomolecules       Date:  2021-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.